Show Summary Details
Page of

Urinary sepsis: vancomycin-resistant enterococci 

Urinary sepsis: vancomycin-resistant enterococci
Urinary sepsis: vancomycin-resistant enterococci

Julia Howard

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 28 June 2022

Enterococci spp including vancomycin-resistant enterococci (VRE) are low virulence organisms; however, treatment options are limited and so treatment of invasive infection can cause management issues. Enterococci are resident in the gastrointestinal (GI) tract and most commonly cause infection originating in the GI or urinary tracts. Bacteraemia may lead to the spread of infection to other sites including, rarely, the heart valves, leading to infective endocarditis. This chapter highlights a case of VRE bacteraemia associated with pyonephrosis in which removal of the source (drainage of pus) was the most important intervention. Classification by microbiology, epidemiology, and antibiotic choices for VRE infections are also discussed.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.